Entscheidungen
RechtsgrundsatzCourt must consider the likelihood of EPO opposition/TBA outcome when assessing validityAlle zurücksetzen
| Datum | Fall | Kammer | Verfahrensart | Antrag | Ausgang | Zusammenfassung |
|---|---|---|---|---|---|---|
| 2024-06-26 | UPC_CFI_124/2024 | Hamburg LD | Application for provisional measures | Einstweilige Verfügung | PI abgelehnt | The Hamburg Local Division dismissed Alexion Pharmaceuticals' application for a preliminary injunction against multiple Amgen entities based on EP 3 167 888, holding that while infringement could be established the court lacked sufficient certainty of patent validity given the EPO's repeated rejection of sequence correction attempts for SEQ ID NO:4. |